NCT01447849View on ClinicalTrials.gov

Lubiprostone and Mucus Secretion in Patients With Chronic Constipation

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Constipation
Interventions
DRUG

lubiprostone

24mcg twice a day (BID) 1 week

DRUG

placebo

Placebo pills twice a day for one week.

Trial Locations (1)

79905

Texas Tech University Health Sciences Center, El Paso

All Listed Sponsors
lead

Texas Tech University Health Sciences Center, El Paso

OTHER

NCT01447849 - Lubiprostone and Mucus Secretion in Patients With Chronic Constipation | Biotech Hunter | Biotech Hunter